# Antiviral Prophylaxis and Infant Vaccination to Prevent Perinatal Hepatitis B Infection

> **NCT03343431** · PHASE3 · ACTIVE_NOT_RECRUITING · sponsor: **Institut de Recherche pour le Developpement** · enrollment: 504 (actual)

## Conditions studied

- Hepatitis B
- Pregnancy

## Interventions

- **DRUG:** Anti-HBV antiviral prophylaxis

## Key facts

- **NCT ID:** NCT03343431
- **Lead sponsor:** Institut de Recherche pour le Developpement
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2018-08-02
- **Primary completion:** 2023-05-13
- **Final completion:** 2025-06-30
- **Target enrollment:** 504 (ACTUAL)
- **Last updated:** 2025-05-30

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03343431

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03343431, "Antiviral Prophylaxis and Infant Vaccination to Prevent Perinatal Hepatitis B Infection". Retrieved via AI Analytics 2026-07-04 from https://api.ai-analytics.org/clinical/NCT03343431. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*